252 related articles for article (PubMed ID: 3656172)
1. Vasoactive intestinal polypeptide regulation of rabbit renal adenylate cyclase activity in vitro.
Griffiths NM; Simmons NL
J Physiol; 1987 Jun; 387():1-17. PubMed ID: 3656172
[TBL] [Abstract][Full Text] [Related]
2. Distribution of vasoactive intestinal peptide-sensitive adenylate cyclase activity along the rabbit nephron.
Griffiths NM; Chabardès D; Imbert-Teboul M; Siaume-Perez S; Morel F; Simmons NL
Pflugers Arch; 1988 Sep; 412(4):363-8. PubMed ID: 3174393
[TBL] [Abstract][Full Text] [Related]
3. Vasoactive intestinal peptide stimulation of human renal adenylate cyclase in vitro.
Charlton BG; Neal DE; Simmons NL
J Physiol; 1990 Apr; 423():475-84. PubMed ID: 2167366
[TBL] [Abstract][Full Text] [Related]
4. Vasoactive intestinal peptide stimulation of renal adenylate cyclase and antagonism by (4Cl-D-Phe6Leu17)VIP.
Griffiths NM; Simmons NL; Rivier J
Pflugers Arch; 1989 Jun; 414(2):222-7. PubMed ID: 2755776
[TBL] [Abstract][Full Text] [Related]
5. Vasoactive intestinal peptide stimulation of adenylate cyclase activity in isolated rabbit renal arterial microvessels.
Griffiths NM; Simmons NL
Exp Physiol; 1990 Jul; 75(4):601-4. PubMed ID: 2223058
[TBL] [Abstract][Full Text] [Related]
6. Vasoactive intestinal peptide control of renal adenylate cyclase: in vitro studies of canine renal membranes and cultured canine renal epithelial (MDCK) cells.
Griffiths NM; Rugg EL; Simmons NL
Q J Exp Physiol; 1989 May; 74(3):339-53. PubMed ID: 2546173
[TBL] [Abstract][Full Text] [Related]
7. Vasoactive intestinal peptide and intraocular pressure: adenylate cyclase activation and binding sites for vasoactive intestinal peptide in membranes of ocular ciliary processes.
Mittag TW; Tormay A; Podos SM
J Pharmacol Exp Ther; 1987 Apr; 241(1):230-5. PubMed ID: 3033201
[TBL] [Abstract][Full Text] [Related]
8. Interactions between vasoactive intestinal peptide and dopamine in the rabbit retina: stimulation of a common adenylate cyclase.
Pachter JA; Lam DM
J Neurochem; 1986 Jan; 46(1):257-64. PubMed ID: 2415680
[TBL] [Abstract][Full Text] [Related]
9. Distribution of vasoactive intestinal peptide-sensitive adenylate cyclase activity along the nephron.
Edwards RM
Eur J Pharmacol; 1988 Nov; 157(2-3):227-30. PubMed ID: 3224639
[TBL] [Abstract][Full Text] [Related]
10. Heart receptors for VIP, PHI and secretin are able to activate adenylate cyclase and to mediate inotropic and chronotropic effects. Species variations and physiopathology.
Christophe J; Waelbroeck M; Chatelain P; Robberecht P
Peptides; 1984; 5(2):341-53. PubMed ID: 6089134
[TBL] [Abstract][Full Text] [Related]
11. Vasoactive intestinal peptide (VIP) and peptide having N-terminal histidine and C-terminal isoleucine amide (PHI) stimulate adenylate cyclase activity in human heart membranes.
Taton G; Chatelain P; Delhaye M; Camus JC; De Neef P; Waelbroeck M; Tatemoto K; Robberecht P; Christophe J
Peptides; 1982; 3(6):897-900. PubMed ID: 6897744
[TBL] [Abstract][Full Text] [Related]
12. [D-Phe4]peptide histidine-isoleucinamide ([D-Phe4]PHI), a highly selective vasoactive-intestinal-peptide (VIP) agonist, discriminates VIP-preferring from secretin-preferring receptors in rat pancreatic membranes.
Robberecht P; Coy DH; De Neef P; Camus JC; Cauvin A; Waelbroeck M; Christophe J
Eur J Biochem; 1987 Jun; 165(2):243-9. PubMed ID: 3036504
[TBL] [Abstract][Full Text] [Related]
13. Characterization of binding sites for VIP-related peptides and activation of adenylate cyclase in developing pancreas.
Le Meuth V; Farjaudon N; Bawab W; Chastre E; Rosselin G; Guilloteau P; Gespach C
Am J Physiol; 1991 Feb; 260(2 Pt 1):G265-74. PubMed ID: 1847591
[TBL] [Abstract][Full Text] [Related]
14. Characterization of adenylyl cyclase stimulated by VIP in rat and mouse peritoneal macrophage membranes.
Pozo D; Segura JJ; Carrero I; Guijarro LG; Prieto JC; Calvo JR
Biochim Biophys Acta; 1996 Jul; 1312(3):249-54. PubMed ID: 8703995
[TBL] [Abstract][Full Text] [Related]
15. Vasoactive intestinal polypeptide-related peptides modulate tyrosine hydroxylase gene expression in PC12 cells through multiple adenylate cyclase-coupled receptors.
Wessels-Reiker M; Basiboina R; Howlett AC; Strong R
J Neurochem; 1993 Mar; 60(3):1018-29. PubMed ID: 8094740
[TBL] [Abstract][Full Text] [Related]
16. Vasoactive intestinal peptide effects on GH3 pituitary tumor cells: high affinity binding, affinity labeling, and adenylate cyclase stimulation. Comparison with peptide histidine isoleucine and growth hormone-releasing factor.
Wood CL; O'Dorisio MS; Vassalo LM; Malarkey WB; O'Dorisio TM
Regul Pept; 1985 Nov; 12(3):237-48. PubMed ID: 3001842
[TBL] [Abstract][Full Text] [Related]
17. Cerebral vascular adenylate cyclase: evidence for coupling to receptors for vasoactive intestinal peptide and parathyroid hormone.
Huang M; Rorstad OP
J Neurochem; 1984 Sep; 43(3):849-56. PubMed ID: 6086840
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of the adenylyl cyclase activity in human endometrial membranes by VIP and related peptides.
Bajo AM; Guijarro LG; Juarranz MG; Valenzuela P; Martinez P; Prieto JC
Biosci Rep; 1993 Apr; 13(2):69-77. PubMed ID: 8397008
[TBL] [Abstract][Full Text] [Related]
19. Adenylate cyclase stimulation by VIP in rat and human parotid membranes.
van Bogaert P; Soukias Y; Dehaye JP; Lambert M; Poloczek P; Winand J; Mayer R; Christophe J
Regul Pept; 1987 Jun; 17(6):339-48. PubMed ID: 3602475
[TBL] [Abstract][Full Text] [Related]
20. The effect of vasoactive intestinal polypeptide (VIP) on forskolin stimulated adenylate cyclase in the caudate-putamen of the rat.
Moser A; Drescher S
Exp Brain Res; 1990; 79(2):383-7. PubMed ID: 2323384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
